Skip to main content

Closed

TOVX: Theriva Biologics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin-7245.0%

ROIC-76.2%

Financially safe

Stretched

Debt / equity0.24×

Interest coverage0.0×

Current ratio1.63×

Theriva Biologics, Inc.

TOVXNew York Stock Exchange Arca·USD·Closed

Theriva Biologics, Inc.

TOVXNew York Stock Exchange Arca·USD·Closed

$0.23

+2.56%

$0.23

+$0.01 (2.56%)

52W Range

10thpctl

Volume

0.10×avg

Mkt Cap

10.48MUSD

P/E

-0.1TTM

Div Yield

–ann

52W Range

10thpctl

Volume

0.10×avg

Market Cap

10.48MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings